核因子κB受体激活因子(RANk)多克隆抗体
Polyclonal Antibody to Receptor Activator Of Nuclear Factor Kappa B (RANk)
CD265; TNFRSF11A; TNFRSF11-A; ODFR; OFE; TRANCER; Osteoclast differentiation factor receptor; Tumor Necrosis Factor Receptor Superfamily,Member 11a,NFKB Activator
- 编号PAC057Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPC057Hu01-核因子κB受体激活因子(RANk)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性状液体
- 浓度0.5mg/ml
- 且适物种Mus musculus (Mouse,小鼠)
- 应用WB,IHC
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对RANk的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别RANk。
用法
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPC057Hu01 | 核因子κB受体激活因子(RANk)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APC057Hu01 | 核因子κB受体激活因子(RANk)活性蛋白 | Cell culture; Activity Assays. |
PAC057Hu01 | 核因子κB受体激活因子(RANk)多克隆抗体 | WB,IHC |
MAC057Hu22 | 核因子κB受体激活因子(RANk)单克隆抗体 | WB; IHC; ICC; IP. |
MAC057Hu21 | 核因子κB受体激活因子(RANk)单克隆抗体 | WB |
SEC057Hu | 核因子κB受体激活因子(RANk)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC057Hu | 核因子κB受体激活因子(RANk)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
European Journal of Immunology | Human polymorphonuclear neutrophils express the receptor activator of NFκB (RANK) and are activated by its ligand RANKL [Wiley: source] |
International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity [PubMed: 23452891] |
Bulletin of Experimental Biology and Medicine | Receptor Activator of Nuclear Transcription Factor NF-κB(RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors [DOI:110.1007/s10517-017-3832-9] |
BIOSCIENCE REPORTS | IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1/HIF-1α signaling pathway [Pubmed: 32347300] |
留言咨询